Cited by 476Mitochondrial Function and PathologyAdipose Tissue and MetabolismAutophagy in Disease and Therapy

The DOI matches its Crossref record; 298 of the 314 references it cites were found in a registry or an index; 13 of the 236 sources its claims cite were checked for support.

Mitochondrial Uncoupling: A Key Controller of Biological Processes in Physiology and Diseases

Open access

Abstract

Mitochondrial uncoupling can be defined as a dissociation between mitochondrial membrane potential generation and its use for mitochondria-dependent ATP synthesis. Although this process was originally considered a mitochondrial dysfunction, the identification of UCP-1 as an endogenous physiological uncoupling protein suggests that the process could be involved in many other biological processes. In this review, we first compare the mitochondrial uncoupling agents available in term of mechanistic and non-specific effects. Proteins regulating mitochondrial uncoupling, as well as chemical compounds with uncoupling properties are discussed. Second, we summarize the most recent findings linking mitochondrial uncoupling and other cellular or biological processes, such as bulk and specific autophagy, reactive oxygen species production, protein secretion, cell death, physical exercise, metabolic adaptations in adipose tissue, and cell signaling. Finally, we show how mitochondrial uncoupling could be used to treat several human diseases, such as obesity, cardiovascular diseases, or neurological disorders.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

Mitochondrial uncoupling is a dissociation between mitochondrial membrane potential generation and ATP synthesis, and this review argues it is not merely dysfunction but a regulator of autophagy, ROS, secretion, cell death, exercise adaptation, adipose biology, and disease. It surveys natural and synthetic uncouplers and their therapeutic potential, while cautioning that most mechanistic evidence comes from non-specific agents such as DNP and FCCP.

Key findings

  • Basal proton leak can account for up to 30–50% of resting cellular metabolic rate, and ANTs can account for up to 50% of basal mitochondrial membrane proton conductance.
  • UCP-1 is a well-established uncoupling protein, but uncoupling properties of other UCPs remain debated; UCP-3 expression is 200–700-fold lower than UCP-1 in mouse skeletal muscle, so overexpression models may be artefactual.
  • Mitochondrial uncoupling is linked to bulk and specific autophagy/mitophagy, ROS production, protein secretion, cell death, physical exercise, adipose tissue browning, and cell signaling; mitochondrial ROS release can account for 0.1–0.2% of O₂ consumed in rat tissues.
  • Therapeutic potential is discussed for obesity, diabetes, cardiovascular disease, and neurological disorders; controlled-release DNP in rats decreased fasting plasma glucose, fatty acids by 30%, TAG, HDL by 30%, and hyperinsulinemia by 50%, with 50–90% decreases in TAG in plasma, liver, and skeletal muscle. DNP at 30 °C decreased energy expenditure by 17% and weight loss by 23% in female C57BL/6J mice, while no significant effect was observed at 22 °C.

Methods

  • Narrative review comparing mitochondrial uncoupling agents, uncoupling proteins (UCPs and ANTs), and chemical compounds with uncoupling properties.
  • Synthesizes cited literature on cellular and biological processes including autophagy, mitophagy, ROS production, protein secretion, cell death, physical exercise, adipose tissue browning, and cell signaling.
  • Discusses possible use of mitochondrial uncouplers in human diseases such as obesity, cardiovascular diseases, and neurological disorders; no primary experimental data or systematic search strategy is reported.

Limitations

  • The authors state that most mechanistic studies have focused on classical but non-specific uncouplers such as DNP or FCCP, making it difficult to discriminate effects directly imputable to mitochondrial uncoupling from unspecific effects.
  • The authors state that cellular consequences have not been studied rigorously and that continuous development of mitochondria-specific uncoupling agents is needed to improve knowledge and safety.
  • Evident from the text: this is a narrative review without stated systematic search or inclusion criteria, and many findings are described as conflicting or dependent on species, cell type, temperature, membrane composition, and uncoupler used.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/cells8080795

Cites

298 of 298 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Overview of the cellular consequences of mitochondrial uncoupling. Abbreviations: ADP (Adenosine DiPhosphate), AMPK (Adenosine Monophosphate-Activated Protein Kinase), ATP (Adenosine Triphosphate), ATPs (ATPsynthase), CytC (Cytochrome C), FFA (Free Fatty Acid), LD (Lipid Droplet), ROS (Reactive Oxygen Species), NAD (Nicotinamide Adenine Dinucleotide). Induction of mitochondrial uncoupling by use of synthetic or natural uncoupling agents or by activating dedicated proteins, such as UCPs or ANTs, can trigger several cellular mechanisms. The first effect, and the most well-known, is the inhibition of mitochondrial ATP production by ATP synthase due to the dissipation of the mitochondrial proton gradient. This energy will be dissipated as heat (thermogenesis). The decrease in cytosolic ATP will be sensed by AMPK and lead to its activation. In addition, the decrease in mitochondrial potential membrane will also modify ROS generation. In order to cope with this energy loss, autophagy will also be triggered (both bulk and specific forms of autophagy). Lipid droplets (LD) will be degraded by a form of autophagy and help to fuel the cell with lipids. Loss of the mitochondrial potential membrane will also allow the identification of these dysfunctional mitochondria by autophagy (mitophagy). Mitochondrial uncoupling can also help to protect cells against cell death and apoptosis but can also promote it, according to the cell type, mitochondrial uncoupler and mitochondrial uncoupling intensity considered. Finally, the use of non-specific mitochondrial uncouplers, such as FCCP or DNP, could alter the homeostasis of several ions, such as Ca2+, Na+ and K+ (at the cytosolic, mitochondria, or lysosomal levels), which will lead to a decrease in protein secretion and plasma membrane (de)polarization, respectively.
Figure 1 Overview of the cellular consequences of mitochondrial uncoupling. Abbreviations: ADP (Adenosine DiPhosphate), AMPK (Adenosine Monophosphate-Activated Protein Kinase), ATP (Adenosine Triphosphate), ATPs (ATPsynthase), CytC (Cytochrome C), FFA (Free Fatty Acid), LD (Lipid Droplet), ROS (Reactive Oxygen Species), NAD (Nicotinamide Adenine Dinucleotide). Induction of mitochondrial uncoupling by use of synthetic or natural uncoupling agents or by activating dedicated proteins, such as UCPs or ANTs, can trigger several cellular mechanisms. The first effect, and the most well-known, is the inhibition of mitochondrial ATP production by ATP synthase due to the dissipation of the mitochondrial proton gradient. This energy will be dissipated as heat (thermogenesis). The decrease in cytosolic ATP will be sensed by AMPK and lead to its activation. In addition, the decrease in mitochondrial potential membrane will also modify ROS generation. In order to cope with this energy loss, autophagy will also be triggered (both bulk and specific forms of autophagy). Lipid droplets (LD) will be degraded by a form of autophagy and help to fuel the cell with lipids. Loss of the mitochondrial potential membrane will also allow the identification of these dysfunctional mitochondria by autophagy (mitophagy). Mitochondrial uncoupling can also help to protect cells against cell death and apoptosis but can also promote it, according to the cell type, mitochondrial uncoupler and mitochondrial uncoupling intensity considered. Finally, the use of non-specific mitochondrial uncouplers, such as FCCP or DNP, could alter the homeostasis of several ions, such as Ca2+, Na+ and K+ (at the cytosolic, mitochondria, or lysosomal levels), which will lead to a decrease in protein secretion and plasma membrane (de)polarization, respectively.CC BY · PubMed Central
Figure 2 Effect of mitochondrial uncoupling proteins on mitochondrial ROS generation. Abbreviations: ANT-1 (Adenine Nucleotide Transferase-1), ATPs (ATPsynthase), IMS (Inter Membrane Space of Mitochondria), ROS (Reactive Oxygen Species), UCP-1 (Uncoupling Protein-1). Mitochondrial ATP production relies on the coupling between the proton gradient on either side of the inner mitochondrial membrane and the use of this proton-motive force to feed the mitochondrial ATP synthase complex. However, this coupling is not complete and could lead to the production of ROS. Many different ROS can be produced by the mitochondria, including superoxide anion (O2•−), which is dismuted into hydrogen peroxide (H2O2), and could generate peroxinitrite (ONOO-). Many other parameters can increase the ROS production rate, including change in cytosolic or mitochondrial pH, the redox cellular state, or high local O2 availability. UCP-1 is a protein specialized in proton transport across the inner mitochondrial membrane. By uncoupling the mitochondrial respiration, it decreases the ROS generation rate. Of note, this effect is likely to be dependent on cell type and species. At the opposite, the role of UCP-2 and UCP-3, two other members of UCP protein family but with a less defined proton transport capacity, is clearer and consists in ROS reduction. Activation of ANT-1 also leads to a decrease in ROS production. Of note, high ROS production will also lead to a cellular adaptation and to an increase in UCPs expression (dashed line).
Figure 2 Effect of mitochondrial uncoupling proteins on mitochondrial ROS generation. Abbreviations: ANT-1 (Adenine Nucleotide Transferase-1), ATPs (ATPsynthase), IMS (Inter Membrane Space of Mitochondria), ROS (Reactive Oxygen Species), UCP-1 (Uncoupling Protein-1). Mitochondrial ATP production relies on the coupling between the proton gradient on either side of the inner mitochondrial membrane and the use of this proton-motive force to feed the mitochondrial ATP synthase complex. However, this coupling is not complete and could lead to the production of ROS. Many different ROS can be produced by the mitochondria, including superoxide anion (O2•−), which is dismuted into hydrogen peroxide (H2O2), and could generate peroxinitrite (ONOO-). Many other parameters can increase the ROS production rate, including change in cytosolic or mitochondrial pH, the redox cellular state, or high local O2 availability. UCP-1 is a protein specialized in proton transport across the inner mitochondrial membrane. By uncoupling the mitochondrial respiration, it decreases the ROS generation rate. Of note, this effect is likely to be dependent on cell type and species. At the opposite, the role of UCP-2 and UCP-3, two other members of UCP protein family but with a less defined proton transport capacity, is clearer and consists in ROS reduction. Activation of ANT-1 also leads to a decrease in ROS production. Of note, high ROS production will also lead to a cellular adaptation and to an increase in UCPs expression (dashed line).CC BY · PubMed Central
Figure 3 Effect of exercise on mitochondrial uncoupling and peripheral organs. Abbreviations: ANT-1 (Adenine Nucletotide Transferase-1), BAT (Brown Adipose Tissue), UCP-1 (Uncoupling Protein-1), WAT (White Adipose Tissue). Different kinds of physical exercise (acute and chronic) trigger mitochondrial uncoupling in skeletal muscle, by activating and by increasing both UCP-1 and ANT-1 expression. Of note, molecular mechanisms triggered differ according to the species considered and are not yet entirely defined. Activation of mitochondrial uncoupling in skeletal muscle also reduces oxidative stress and induces mitochondrial adaptations (including increase in mitochondrial mass, increase in respiratory chain component abundance). Physical exercise also has an impact on adipose tissues. In BAT, mitochondrial uncoupling will be activated (UCP-1 dependent), while it will be attenuated in WAT. Browning of WAT will also be induced, an effect dependent, at least partially, on irisin secretion by skeletal muscle. An association between decreased Firmicutes level in gastrointestinal tract (associated with physical exercise) and WAT browning has also been observed. In case of sustained physical exercise, adipose tissue mass will decrease which will alleviate both oxidative stress and secretion of proinflammatory cytokines.
Figure 3 Effect of exercise on mitochondrial uncoupling and peripheral organs. Abbreviations: ANT-1 (Adenine Nucletotide Transferase-1), BAT (Brown Adipose Tissue), UCP-1 (Uncoupling Protein-1), WAT (White Adipose Tissue). Different kinds of physical exercise (acute and chronic) trigger mitochondrial uncoupling in skeletal muscle, by activating and by increasing both UCP-1 and ANT-1 expression. Of note, molecular mechanisms triggered differ according to the species considered and are not yet entirely defined. Activation of mitochondrial uncoupling in skeletal muscle also reduces oxidative stress and induces mitochondrial adaptations (including increase in mitochondrial mass, increase in respiratory chain component abundance). Physical exercise also has an impact on adipose tissues. In BAT, mitochondrial uncoupling will be activated (UCP-1 dependent), while it will be attenuated in WAT. Browning of WAT will also be induced, an effect dependent, at least partially, on irisin secretion by skeletal muscle. An association between decreased Firmicutes level in gastrointestinal tract (associated with physical exercise) and WAT browning has also been observed. In case of sustained physical exercise, adipose tissue mass will decrease which will alleviate both oxidative stress and secretion of proinflammatory cytokines.CC BY · PubMed Central
Figure 4 Regulation of browning of white adipocytes. Abbreviations: IL (Interleukin), UCP-1 (Uncoupling Protein-1). White adipocytes are a cell-type specialized in lipid storage but also characterized by an important endocrine function. These cells are characterized by an unilocular lipid droplet and a reduced mitochondrial mass. During the last decades, it was demonstrated that these cells could transdifferentiate into brown adipocytes under certain circumstances such as cold exposure, change in gut microbiota (decrease in Firmicutes level) or exposition to cytokine (such as IL-18), myokine (such as irisin) or chemical compounds (such as retinoic acid). This process can be inhibited by several conditions including exposition to proinflammatory cytokines such as IL-6 or IL-1β or to oxidative stress. A more detailed list of pro/anti-browning conditions can be found in the main text. The adipocyte browning is characterized by an increase in lipogenesis and changes in terms of lipid droplet number and composition. The hallmark of adipocyte browning is the induction of UCP-1 expression. Of note, if it is considered that adipocyte browning is accompanied by UCP-1 activation, it was recently suggested that UCP-1 could also play a key role in lipid metabolism. Activation of UCP-1 is often accompanied by a decrease in oxidative stress in adipose tissues. Brown adipocytes can also differentiate into white adipocytes. This process, named adipose tissue whitening, is accompanied an increase in mitophagy in order to clear cells from UCP-1 expressing mitochondria.
Figure 4 Regulation of browning of white adipocytes. Abbreviations: IL (Interleukin), UCP-1 (Uncoupling Protein-1). White adipocytes are a cell-type specialized in lipid storage but also characterized by an important endocrine function. These cells are characterized by an unilocular lipid droplet and a reduced mitochondrial mass. During the last decades, it was demonstrated that these cells could transdifferentiate into brown adipocytes under certain circumstances such as cold exposure, change in gut microbiota (decrease in Firmicutes level) or exposition to cytokine (such as IL-18), myokine (such as irisin) or chemical compounds (such as retinoic acid). This process can be inhibited by several conditions including exposition to proinflammatory cytokines such as IL-6 or IL-1β or to oxidative stress. A more detailed list of pro/anti-browning conditions can be found in the main text. The adipocyte browning is characterized by an increase in lipogenesis and changes in terms of lipid droplet number and composition. The hallmark of adipocyte browning is the induction of UCP-1 expression. Of note, if it is considered that adipocyte browning is accompanied by UCP-1 activation, it was recently suggested that UCP-1 could also play a key role in lipid metabolism. Activation of UCP-1 is often accompanied by a decrease in oxidative stress in adipose tissues. Brown adipocytes can also differentiate into white adipocytes. This process, named adipose tissue whitening, is accompanied an increase in mitophagy in order to clear cells from UCP-1 expressing mitochondria.CC BY · PubMed Central
Figure 5 Systemic effect of mitochondrial uncouplers on different organs in the context of obesity and type 2 diabetes. Abbreviations: HDL (High Density Lipoprotein), IFNγ (Interferon γ), IL (Interleukin), MCP-1 (Monocyte Chemoattractant Protein-1), NAFLD (Non-Alcoholic Fatty Liver Disease), NPY (Neuropeptide Y), POMC (Proopiomelanocortin), TAG (Triacylglycerol), TNF-α (Tumor Necrosis Factor-α). Use of systemic mitochondrial uncouplers, such as DNP or FCCP, will impact the functions of multiples organs. Some of these effects could be beneficial for the treatment of obesity and associated complications, such as type 2 diabetes. First, the global mitochondrial uncoupling induced by these molecules and the subsequent increase in cell respiration will increase global energy expenditure. As a consequence, lipid stores of different organs will be mobilized (increase in lipolysis, decrease in lipogenesis, and decrease in total TAG content and circulating levels). A global decrease in lipid stores will also help to alleviate the proinflammatory state seen in adipose tissues of obese patients. Patients will also be protected against NAFLD. Mitochondrial uncouplers also exert a direct effect on the brain and could affect the activity of NPY (decrease) and POMC (increase) neuron activity. Finally, it is important to stress that excessive mitochondrial uncoupling (due to excessive dosage and/or sensitivity to these compounds) will induce many complications, such as acute cataract, sensory axonal polyneuropathy, fever, tachycardia, sweating, nausea, rash, breathing difficulties, abdominal pain, agitation, headache, and, ultimately, death. Therefore, if mitochondrial uncoupling induction could be beneficial, it should be achieved by using highly mitochondria-specific and safe compounds, which remain to be developed.
Figure 5 Systemic effect of mitochondrial uncouplers on different organs in the context of obesity and type 2 diabetes. Abbreviations: HDL (High Density Lipoprotein), IFNγ (Interferon γ), IL (Interleukin), MCP-1 (Monocyte Chemoattractant Protein-1), NAFLD (Non-Alcoholic Fatty Liver Disease), NPY (Neuropeptide Y), POMC (Proopiomelanocortin), TAG (Triacylglycerol), TNF-α (Tumor Necrosis Factor-α). Use of systemic mitochondrial uncouplers, such as DNP or FCCP, will impact the functions of multiples organs. Some of these effects could be beneficial for the treatment of obesity and associated complications, such as type 2 diabetes. First, the global mitochondrial uncoupling induced by these molecules and the subsequent increase in cell respiration will increase global energy expenditure. As a consequence, lipid stores of different organs will be mobilized (increase in lipolysis, decrease in lipogenesis, and decrease in total TAG content and circulating levels). A global decrease in lipid stores will also help to alleviate the proinflammatory state seen in adipose tissues of obese patients. Patients will also be protected against NAFLD. Mitochondrial uncouplers also exert a direct effect on the brain and could affect the activity of NPY (decrease) and POMC (increase) neuron activity. Finally, it is important to stress that excessive mitochondrial uncoupling (due to excessive dosage and/or sensitivity to these compounds) will induce many complications, such as acute cataract, sensory axonal polyneuropathy, fever, tachycardia, sweating, nausea, rash, breathing difficulties, abdominal pain, agitation, headache, and, ultimately, death. Therefore, if mitochondrial uncoupling induction could be beneficial, it should be achieved by using highly mitochondria-specific and safe compounds, which remain to be developed.CC BY · PubMed Central

Verification

Claims the paper makes

159 Not checked yet · 10 Own interpretation · 4 No basis given · 3 Supported · 2 Partly supported · 1 Supported so far · 1 Mixed support · accuracy not yet measured

Verify all 223 references — free account

Show all 106 claims

  • It may state two separate claims as one. 63
  • Probably not a substantial claim. 14
  • The quote only partly states this claim. 1
74 of 74
  • The paper relies on this without support.

    During browning, UCP-1 must be expressed, imported into mitochondria, and activated; during whitening, UCP-1 protein must be cleared from the mitochondrial population.

    “During browning, UCP-1 must be expressed, imported in mitochondria, and activated; while, conversely, UCP-1 protein must be cleared from the mitochondrial population during whitening (Figure 4).”
  • The paper relies on this without support.

    The beige-to-white adipocyte transition is often associated with mitochondrial disposal by mitophagy.

    “The beige-to-white adipocyte transition is often associated with a mitochondrial disposal by mitophagy.”
  • The paper relies on this without support.

    The cellular consequences of mitochondrial uncoupling have not been studied rigorously.

    “Unfortunately, the cellular consequences have not been studied rigorously.”
3 of 3

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

1 retracted

Show all 314 references

Research works printed but not linked: 2

  1. Gnaiger, E., Aasander Frostner, E., Abdul Karim, N., Abdel-Rahman, E.A., Abumrad, N.A., Acuna-Castroviejo, D., Adiele, R.C., Ahn, B., Alencar, M.B., and Ali, S.S. (2019). Mitochondrial respiratory states and rates. MitoFit Preprint Arch.
  2. Garlid, 2018, Mitochondrial uncoupling proteins: Subtle regulators of cellular redox signaling, Antioxid. Redox Signal., 29, 667

Cited by

Sorted by citations

Metadata

Authors
Demine, S., Renard, P., & Arnould, T.
Affiliations
  • Université Libre de Bruxelles (BE)
  • University of Namur (BE)
Corresponding author
Arnould, Thierry
Venue
Cells
Publisher
MDPI AG
Published
2019-07-30
Volume
8
Issue
8
Pages
795
ISSN
2073-4409 (ISSN-L)
OpenAlex
W2964584752
Cited by
476
References
314
Citations by year
2026: 47 · 2025: 77 · 2024: 78 · 2023: 89 · 2022: 70 · 2021: 74 · 2020: 35 · 2019: 5
FWCI
4.06
Type
journal article
Language
en
Open access
Locations
  • Cells (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Repository of the University of Namur (publishedVersion, cc-by)
  • Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Fonds De La Recherche Scientifique - FNRS (Crédit de Recherche J.0034.18, Crédit de Recherche 19497337)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
Keywords
mitochondrial uncoupling, UCP1, uncoupling proteins, mitochondrial membrane potential, ATP production, autophagy, reactive oxygen species, protein secretion, cell death, physical activity, adipose tissue metabolism, signal transduction, obesity, cardiovascular disease, neurological disorders, disease therapy
MeSH terms
Mitochondrial Uncoupling Proteins, Animals, Autophagy, Humans, Mitochondria, Oxidative Phosphorylation, Uncoupling Agents, Signal Transduction, Reactive Oxygen Species

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review